A Win For ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. (CLPT:NASDAQ) soared at $4.82, a gain of 33.1%. On Thu 16 Jul 20, CLPT:NASDAQ touched a New 2-Week Intraday High of $3.83. The stock got featured on our News Catalysts scanner on Fri 17 Jul 20 at 09:33 AM in the 'INVESTOR UPDATE' category. From Thu 02 Jul 20, the stock recorded 44.44% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About ClearPoint Neuro, Inc. (CLPT:NASDAQ)
MRI Interventions Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It has two product platforms: ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace system, which is under development, to be used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint Neuro Intervention System and The ClearTrace Cardiac Intervention System.
Top 10 Gainers:
- Verona Pharma plc (VRNA:NASDAQ), 111.62%
- Salem Media Group, Inc. (SALM:NASDAQ), 80.95%
- Cohen & Company Inc. (COHN:NYSEMKT), 54.14%
- AutoWeb, Inc. (AUTO:NASDAQ), 44.27%
- Ocwen Financial Corporation (OCN:NYSE), 42.1%
- Vaccinex, Inc. (VCNX:NASDAQ), 40.28%
- Allena Pharmaceuticals, Inc. (ALNA:NASDAQ), 38.46%
- Sunlands Technology Group (STG:NYSE), 34.23%
- Checkpoint Therapeutics, Inc. (CKPT:NASDAQ), 33.83%
- ClearPoint Neuro, Inc. (CLPT:NASDAQ), 33.15%